D'oxyva
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
790 E Colorado Blvd Fl 9, Pasadena, Cali...Phone Number
(626) 240-0956Website
www.doxyva.comRevenue
$5.2 MillionIndustry
About D'oxyva
Is D'oxyva your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at D'oxyva
Earning: See what the market has to say on D'oxyva recently announced quarterly report
Check out if D'oxyva is spiking on competitors!
Click to see if D'oxyva had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once D'oxyva has new funding data
Product Launch: Get notified when D'oxyva launches new products
Website visits: Recent activity has been detected on your website
D'oxyva, which may be a good buyer, showed buying intent in Masked Content Topic
Check if D'oxyva has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined D'oxyva as Masked Content
Find 2 more new buyers
Compare Similar Companies to D'oxyva
Compare insights from companies similar to D'oxyva, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
D'oxyva
Company Profile Activity
Activity Insights
D'oxyva is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
D'oxyva is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about D'oxyva.
D'oxyva Tech Stack
A closer look at the technologies used by D'oxyva
D'oxyva News & Media
Circularity Healthcare Is Expanding Its Operations to save Severe Diabetics from Amputation with Its Patented Regenerative Solution D'OXYVA with Recovered CO2
Pasadena, California--(Newsfile Corp. - November 1, 2022) - US-based Circularity Healthcare is now expanding its operations to reach millions of people with its advanced drug delivery biotechnology with the help of 18 of the 20 top-ranked US universities. This is a biotech solution that could potentially save the lives of millions of amputees across the world by enhancing their blood flow and nerve activities. D'OXYVA (deoxyhemoglobin vasodilator) is a novel, clinically validated blood flow and.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding D'oxyva
D'OXYVA offers an advanced regenerative health solution designed to alleviate chronic pain, fibromyalgia, arthritis, varicose veins, and chronic wounds, while also enhancing athletic performance. Their clinically-researched, non-invasive technology delivers neurotransmitter molecules through the skin, promoting improved microcirculation and tissue... Read More